Literature DB >> 8224294

Peripapillary subretinal neovascular membranes: the natural history.

G Silvestri1, D B Archer, P B Johnston.   

Abstract

We studied the natural course of peripapillary subretinal neovascular membranes in 20 eyes. The membranes were either idiopathic in nature or associated with underlying disease. We found that the visual prognosis was related to the behaviour of the membrane and to the patient's age. Patients under the age of 40 years had unilateral disease and a more favourable visual prognosis. Older patients had a uniformly poor visual prognosis and a high incidence of bilateral disease. Fifty-four per cent of patients over 45 years and 62% over 70 years of age had bilateral membranes. In those over the age of 70 years, 75% of untreated eyes lost vision to a level of 3/60 or less in both eyes. The probability of the second eye becoming involved in the older group of patients was 62%. The period of time elapsing between involvement of the first and second eye varied between simultaneous occurrence and a delay of 7 years.

Entities:  

Mesh:

Year:  1993        PMID: 8224294     DOI: 10.1038/eye.1993.78

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  5 in total

1.  Surgical treatment of peripapillary choroidal neovascularisation.

Authors:  Susanne Binder
Journal:  Br J Ophthalmol       Date:  2007-08       Impact factor: 4.638

2.  Prevalence of peripapillary choroidal neovascular membranes (PPCNV) in an elderly UK population-the Bridlington eye assessment project (BEAP): a cross-sectional study (2002-2006).

Authors:  Craig Wilde; Ali Poostchi; Rajnikant L Mehta; Jonathan G Hillman; Hamish K MacNab; Marco Messina; Gaspare Monaco; Stephen A Vernon; Winfried M Amoaku
Journal:  Eye (Lond)       Date:  2018-10-12       Impact factor: 3.775

3.  Surgical treatment of peripapillary choroidal neovascularisation.

Authors:  S Aisenbrey; F Gelisken; P Szurman; K U Bartz-Schmidt
Journal:  Br J Ophthalmol       Date:  2007-02-14       Impact factor: 4.638

4.  Bilateral choroidal neovascularization associated with optic nerve head drusen treated by antivascular endothelial growth factor therapy.

Authors:  Barbara Delas; Lorena Almudí; Anabel Carreras; Mouafk Asaad
Journal:  Clin Ophthalmol       Date:  2012-02-13

Review 5.  Choroidal Thickness Profile in Chorioretinal Diseases: Beyond the Macula.

Authors:  Young Ho Kim; Jaeryung Oh
Journal:  Front Med (Lausanne)       Date:  2021-12-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.